Upgrade to SI Premium - Free Trial

Form 3/A PROCTER & GAMBLE Co For: Jul 01 Filed by: Santos de Azevedo Juliana Monteiro

July 10, 2026 2:29 PM
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person *
Santos de Azevedo Juliana Monteiro
(Last) (First) (Middle)
ONE PROCTER & GAMBLE PLAZA
(Street)
CINCINNATI OH 45202
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
07/01/2026 		3. Issuer Name and Ticker or Trading Symbol
PROCTER & GAMBLE Co [ PG ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
CEO - Grooming
 5. If Amendment, Date of Original Filed (Month/Day/Year)
07/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 19,361.8513
D
Common Stock 331.21
I
International Stock Ownership Plan & Pension Plan
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) (1) Common Stock 70 (2) D
Stock Option (Right to Buy) 10/01/2025 10/01/2032 Common Stock 29,118 128.51 D
Restricted Stock Units (1) (1) Common Stock 447 (3) D
Stock Option (Right to Buy) 10/02/2026 09/30/2033 Common Stock 36,934 145.19 D
Stock Option (Right to Buy) 09/15/2026 09/15/2033 Common Stock 30,662 153.47 D
Restricted Stock Units (1) (1) Common Stock 453 (4) D
Stock Option (Right to Buy) 10/01/2027 09/29/2034 Common Stock 41,343 173.04 D
Stock Option (Right to Buy) 09/13/2027 09/13/2034 Common Stock 14,513 174.08 D
Restricted Stock Units (1) (1) Common Stock 545 (5) D
Stock Option (Right to Buy) 09/29/2028 10/01/2035 Common Stock 36,482 153.18 D
Stock Option (Right to Buy) 09/15/2028 09/14/2035 Common Stock 17,440 156.83 D
Restricted Stock Units (1) (1) Common Stock 73.4061 (6) D
Explanation of Responses:
1. These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.
2. Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2022.
3. Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2023.
4. Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2024.
5. Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2025.
6. Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock.
Remarks:
1. The original Form 3, filed on July 10, 2026, is being amended by this Form 3/A solely to correct an inadvertent, administrative error. The original Form 3 did not have Exhibit 24.1 - Power of Attorney attached. No other changes have been made to the original filing.
/s/ Jennifer Henkel, attorney-in-fact for Juliana M. Santos de Azevedo 07/10/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

ATTACHMENTS / EXHIBITS

POWER OF ATTORNEY (PUBLIC): POWER OF ATTORNEY

Categories

SEC Filings